ArticleJSES international2025
Increasing use of reverse total shoulder arthroplasty in younger adults despite higher complication rates.
Article in JSES international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Outcomes of reverse total shoulder arthroplasty in patients ≤65 years old.Journal of shoulder and elbow arthroplasty · 2026Article
- Long-Term Outcomes of Inverted-Bearing Reverse Shoulder Arthroplasty with Large Polyethylene Glenospheres.Journal of clinical medicine · 2026Article
- Artificial intelligence in shoulder arthroplasty: latest concepts and clinical integration.Journal of orthopaedic surgery and research · 2026Review
- Refining Reverse Shoulder Arthroplasty: From Implant Design to Patient-Specific Strategy.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The indications for reverse total shoulder arthroplasty (rTSA) continue to expand. Although there has been an increase in the use of rTSA across the United States, there are limited data to evaluate the outcomes of rTSA in younger patients. We sought to evaluate the trends of rTSA use in the United States and to evaluate medical and surgical complications in patients under 60 years of age undergoing rTSA. Methods: Patients who underwent primary, elective anatomic or reverse TSAs between January 1, 2016, and December 31, 2020, were identified using the Premier Healthcare Database. Patients undergoing rTSA were divided into groups based on age <60 years old. Annual trends in rTSA use in this age group were assessed. These patients were then propensity matched to patients ≥60 years old undergoing rTSA. Multivariable models were conducted to evaluate the effect of age on 90-day surgical and medical complications. Results: Over the study period, there was a significant increase in the proportion of rTSAs used, with rTSA comprising 48.29% of all TSA in patients <60 years old in 2016 and rising to 58.77% by 2020 (R Conclusion: These results demonstrate the risks associated with younger age in rTSA and suggest that further investigation is required to optimize outcomes of younger patients undergoing rTSA as indications continue to grow.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.